Market Pullback

Showing 9297 articles

Microsoft's Kevin Scott on AI's Rapid Ascent: A Race Between Capability and Application

In a candid discussion, Microsoft CTO Kevin Scott reflects on the breakneck pace of AI advancement, highlighting a growing 'capabilities overhang' where real-world applications struggle to keep up. He points to software development and looming demographic shifts as critical arenas for AI's impact, while cautioning against superficial use and infrastructure bottlenecks.

Business

Merck Navigates Mixed Q4 2025 with Oncology Strength Offsetting Vaccine Slump, Sets Cautious 2026 Outlook

Merck & Co. reported a 5% rise in Q4 2025 revenue to $16.4 billion, powered by its blockbuster cancer drug Keytruda and animal health division. However, a steep 35% drop in Gardasil sales, attributed to weakened demand in Asia, highlighted regional vulnerabilities. The pharmaceutical giant issued initial 2026 guidance projecting modest growth while absorbing a significant one-time charge from its recent Cidara Therapeutics acquisition.